Stay updated on FORTUNE Clinical Trial: NEXThaler vs pMDI in Asthma
Sign up to get notified when there's something new on the FORTUNE Clinical Trial: NEXThaler vs pMDI in Asthma page.

Latest updates to the FORTUNE Clinical Trial: NEXThaler vs pMDI in Asthma page
- Check3 days agoChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.SummaryDifference1%
- Check10 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.3%
- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check46 days agoChange DetectedThe page has removed significant details regarding a study on the efficacy and safety of Foster 100/6mg NEXThaler in asthmatic patients, including the study's purpose, design, and inclusion/exclusion criteria. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference14%
- Check53 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check61 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
Stay in the know with updates to FORTUNE Clinical Trial: NEXThaler vs pMDI in Asthma
Enter your email address, and we'll notify you when there's something new on the FORTUNE Clinical Trial: NEXThaler vs pMDI in Asthma page.